FREE SHIPPING OVER $75.00
Why the Supreme Court Should Pause the FDA’s Abortion-Pill Rule Until the Agency Follows the Law

The dispute over the abortion drug commonly known as the “abortion pill” has shifted from politics to process, raising a question that matters beyond this one medication: whether a federal agency should be allowed to expand its reach without first demonstrating that it has satisfied the legal and scientific obligations that justify its authority. The argument for a judicial pause is not that courts should micromanage medicine, but that agencies should be required to show their work before their decisions are allowed to reshape national policy.

